Data as of Aug 26
| +0.12 / +2.30%|
The 3 analysts offering 12-month price forecasts for Pacific Biosciences of California Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 6.00. The median estimate represents a +31.09% increase from the last price of 5.34.
The current consensus among 4 polled investment analysts is to Hold stock in Pacific Biosciences of California Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.